BALTIMORE — A Pikesville, Maryland, woman is suing the makers and distributors of NuvaRing, citing alleged breach of implied warranty.
Monique Lynch filed a complaint on April 21 in the U.S. District Court Maryland against Organon USA Inc., N.V. Organon, Schering Corporation, Merck and Co. Inc. and Merck Sharp and Dohme, alleging that they failed to properly disclose the known safety hazards associated with the product NuvaRIng.
This is a potential tag-along action that should be transferred to the U.S. District Court for the Eastern District of Missouri to be included in a NuvaRing products liability case, according to court documents.
According to the complaint, the plaintiff alleges that on March 26, 2016, the plaintiff claims she began to experience chest pain and shortness of breath. After visiting Northwest Medical Center, she was advised to discontinue the use of the NuvaRing, a birth control pill because of a pulmonary embolism. As a result, Lynch claims she suffered excruciating pain and medical expenses.
The plaintiff alleges the defendants failed to warn consumers of the serious risks of the product, failed to conduct appropriate testing prior to the NuvaRing being prescribed to consumers and failed to provide proper and full information as to the safety of the product to the U.S. Food and Drug Administration.
The plaintiff requests a trial by jury and seeks judgment in excess of $75,000 for all damages caused, expenses, costs of this action and such further relief as the court deems necessary, just and proper. She is represented by Scott B. Goldstein of Saiontz and Kirk PA in Baltimore and David B. Krangle and Andres F. Alonso of Alonso Krangle LLP in Melville, New York.
U.S. District Court of Maryland Case number 4:17-cv-01324